Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study-Reference-Cited by-同舟云学术

Response level and survival after conventional chemotherapy for multiple myeloma: a Finnish Leukaemia Group study

Published:2009-04-24 Issue:2 Volume:62 Page:109-116
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Oivanen Tiina M.,Kellokumpu-Lehtinen Pirkko,Koivisto Anna-Maija,Koivunen Elli,Palva Ilmari,

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1999.tb01730.x/fullpdf

Reference36 articles.

1. Melphalan in multiple myeloma;Hoogstraten;Blood,1967

2. Melphalan therapy for plasma cell myeloma;Alexanian;Blood,1968

3. Proposed guidelines for clinical studies;Chronic Leukemia-Myeloma Task Force.;Cancer Chemother Rep,1973

4. Interferon-alfa2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial;Nordic Myeloma Study Group.;Ann Intern Med,1996

5. Combination chemotherapy for multiple myeloma;Alexanian;Cancer,1972

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma;Cancer;2017-05-17

2. Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis;European Journal of Haematology;2017-03-20

3. Outcomes of primary refractory multiple myeloma and the impact of novel therapies;American Journal of Hematology;2015-10-06

4. Association of response endpoints with survival outcomes in multiple myeloma;Leukemia;2013-07-19

5. Managing multiple myeloma in the elderly: are we making progress?;Expert Review of Hematology;2011-06